Infectious diseases experts strongly encourage an additional COVID-19 vaccine in spring 2024 for people 65 years of age and older as recommended by the Centers for Disease Control and Prevention.
The Leaders in Epidemiology, Antimicrobial Stewardship and Public Health (LEAP) Fellowship program is an effective model for partnerships between early-career infectious diseases physicians and public health departments, according to new research published in Clinical Infectious Diseases.
Dr. Adaora Adimora exemplified the difference a single person can make in the world. She was an extraordinary leader, infectious diseases physician, researcher, mentor, advocate and colleague committed to addressing the drivers of HIV-related health disparities with a special focus on women.
IDSA is calling on the American Board of Internal Medicine to make substantive changes to its Maintenance of Certification program to make it more clinically meaningful, relevant to scope of practice, supportive of continuous learning and inclusive of all physicians practicing within the infectious diseases discipline.
IDSA congratulates the more than 300 physicians who have matched into an adult or pediatric infectious diseases fellowship. In addition, the number of adult ID fellowship programs continues to grow, providing more opportunities for physicians to train in this essential specialty.
IDSA has announced the recipients of its Antimicrobial Stewardship Centers of Excellence designation. The 14 awarded institutions have created stewardship programs led by infectious diseases-trained physicians and pharmacists.
The dramatic increase in cases — 755% between 2012 and 2021 — represents missed opportunities in the health care system and the need for more resources at the local, state and federal levels.
IDSA and a coalition of medical professional societies released recommendations for modifying the Centers for Medicare and Medicaid Services sepsis metrics to improve sepsis care and outcomes.
Wastewater-based surveillance can accurately monitor influenza A and B and RSV at the population level, making it an objective tool to inform public response to common seasonal illnesses, according to research presented at IDWeek 2023.
Two doses of a live-attenuated COVID-19 vaccine candidate produce a broad cellular immune response when administered intranasally, according to research presented at IDWeek 2023.
The Infectious Diseases Society of America is pleased to honor 11 infectious diseases leaders at IDWeek 2023 with Society Awards for their contributions to infectious diseases and public health.
The HIV Medicine Association is pleased to recognize three members during IDWeek 2023 for their contributions to advancing the field of HIV medicine.